Moderna stock has faced heavy pressure from negative headlines, regulatory setbacks and political uncertainty. See why I ...

The average short interest for the S&P 500 Health Care Index Sector (NYSEARCA:XLV) experienced an increase in June, moving ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.6% in the morning session after JPMorgan added the stock to its ...

The Food and Drug Administration (FDA) granted full approval on Thursday to Moderna’s COVID-19 vaccine for children, making it the first COVID shot for kids aged 6 months to 11 years old that is ...

Moderna is expected to announce its second-quarter results in the upcoming month, and analysts expect a slight reduction in ...

Cambridge: Moderna has received approval from the U.S. Food and Drug Administration (FDA) for the supplemental Biologics ...

Moderna's Spikevax vaccine has been fully approved for children with high-risk conditions, the first vaccine to do so.

Britain launched a life sciences sector plan on Wednesday to a mixed response from the pharmaceutical industry, which ...

Morgan Stanley analyst Terence Flynn maintained a Hold rating on Moderna today and set a price target of $31.00. The company’s shares opened today at $33.30. Elevate Your Invest ...

Major U.S. equities indexes were little changed at midday Wednesday after a report on wholesale inflation showed a surprising ...

The plan – backed with a £2 billion ($2.68 billion) funding pledge – revolves around three overarching objectives, namely ...

UTEC is one of Japan’s largest science and technology-focused VCs, with a portfolio spanning more than 150 companies.